The identification of IL-6 and TNF-alpha as key contributors to post-stroke outcomes suggests that therapeutic strategies targeting cytokine modulation could be pivotal in improving rehabilitation trajectories and reducing long-term disability. The gene discussed is IL6; the disease is Stroke.